Posts

Why public health dietary advice can't be trusted          No major public health or non-governmental health organization has acknowledged the established links between adipose tissue arachidonic acid accumulation and obesity, metabolic syndrome, inflammation, or dementia.     What Major Organizations Say (or Don't Say)      The American Heart Association (AHA) has not only failed to acknowledge adipose tissue AA—it has actively denied that omega-6 intake increases tissue arachidonic acid levels. Their 2009 and 2019 scientific advisories explicitly claim: "Intakes of LA greater than those required to prevent essential acid deficiency do not augment AA levels in tissues" "Higher omega-6 PUFA consumption was associated with neutral or lower levels of inflammatory markers" They recommend 5–10% of calories from omega-6 fats.       What they ignore        Multiple human adipose biopsy studies directly contra...

The adipose tissue arachidonic acid issue

Perplexity AI query:   Compile a list of research papers that specifically link higher adipose tissue arachidonic levels to chronic disease conditions. Response: Based on an extensive literature search, here is a comprehensive compilation of research papers demonstrating associations between elevated adipose tissue arachidonic acid (AA) levels and various chronic disease conditions: Metabolic Syndrome 1. Campos H, Baylin A, Willett WC. (2008). "Adipose Tissue Arachidonic Acid and the Metabolic Syndrome in Costa Rica." Obesity , 16(6): 1427-1433.​ Key Finding: Subjects with greater adipose tissue AA content showed increasing risk of metabolic syndrome across quintiles: OR 1.00, 1.51, 2.40, 3.50, and 6.01 (highest quintile); P<0.0001 for trend Specific Associations: Adipose tissue AA independently associated with abdominal obesity (OR ~20 for highest vs. lowest quintile), hypertriglyceridemia, elevated fasting glucose, and high blood pressure Notable: Association remained s...